Display options
Share it on

PeerJ. 2015 Oct 29;3:e1252. doi: 10.7717/peerj.1252. eCollection 2015.

Brain-derived neurotrophic factor serum levels in genetically isolated populations: gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism.

PeerJ

Davide Carlino, Ruggiero Francavilla, Gabriele Baj, Karolina Kulak, Pio d'Adamo, Sheila Ulivi, Stefania Cappellani, Paolo Gasparini, Enrico Tongiorgi

Affiliations

  1. Psychiatric Clinic, Department of Surgical and Medical Sciences, University of Trieste , Trieste , Italy.
  2. Department of Life Sciences, University of Trieste , Trieste , Italy.
  3. Department of Surgical and Medical Sciences, University of Trieste , Trieste , Italy.
  4. Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" , Trieste , Italy.
  5. Department of Surgical and Medical Sciences, University of Trieste , Trieste , Italy ; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" , Trieste , Italy.

PMID: 26539329 PMCID: PMC4631459 DOI: 10.7717/peerj.1252

Abstract

Anxiety disorders (ADs) are disabling chronic disorders with exaggerated behavioral response to threats. This study was aimed at testing the hypothesis that ADs may be associated with reduced neurotrophic activity, particularly of Brain-derived neurotrophic factor (BDNF), and determining possible effects of genetics on serum BDNF concentrations. In 672 adult subjects from six isolated villages in North-Eastern Italy with high inbreeding, we determined serum BDNF levels and identified subjects with different ADs subtypes such as Social and Specific Phobias (PHSOC, PHSP), Generalized Anxiety Disorder (GAD), and Panic Disorder (PAD). Analysis of the population as a whole or individual village showed no significant correlation between serum BDNF levels and Val66Met polymorphism and no association with anxiety levels. Stratification of subjects highlighted a significant decrease in serum BDNF in females with GAD and males with PHSP. This study indicates low heritability and absence of any impact of the Val66Met polymorphism on circulating concentrations of BDNF. Our results show that BDNF is not a general biomarker of anxiety but serum BDNF levels correlate in a gender-specific manner with ADs subtypes.

Keywords: Anxiety; Brain-derived neurotrophic factor; Generalized Anxiety Disorder; Genome wide analysis; Neurotrophins; Serum biomarkers; Sex factors; Social Phobia; Specific Phobia; Val66Met polymorphism

References

  1. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13208-13 - PubMed
  2. Biol Psychiatry. 2006 Jun 15;59(12):1116-27 - PubMed
  3. Arch Gen Psychiatry. 2005 Jun;62(6):593-602 - PubMed
  4. Psychoneuroendocrinology. 2010 Apr;35(3):364-8 - PubMed
  5. Neuropsychobiology. 2008;57(4):194-9 - PubMed
  6. Bioinformatics. 2007 May 15;23(10):1294-6 - PubMed
  7. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):658-63 - PubMed
  8. World J Biol Psychiatry. 2010 Sep;11(6):763-73 - PubMed
  9. Biol Psychiatry. 2003 Jul 1;54(1):70-5 - PubMed
  10. J Neurosci Methods. 2010 Mar 15;187(1):73-7 - PubMed
  11. Arch Gen Psychiatry. 2005 Jun;62(6):617-27 - PubMed
  12. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):200-4 - PubMed
  13. Med Hypotheses. 2003 Jul;61(1):110-3 - PubMed
  14. Neuropharmacology. 1998 Dec;37(12):1553-61 - PubMed
  15. Psychiatry Clin Neurosci. 2010 Aug;64(4):341-57 - PubMed
  16. Neuropsychopharmacology. 2012 Jun;37(7):1600-11 - PubMed
  17. J Affect Disord. 2012 Dec 15;142(1-3):122-31 - PubMed
  18. Genomics. 2007 Sep;90(3):397-406 - PubMed
  19. Biol Psychiatry. 2005 May 1;57(9):1068-72 - PubMed
  20. Psychoneuroendocrinology. 2011 Feb;36(2):228-39 - PubMed
  21. Eur Psychiatry. 2011 Sep;26(6):339-45 - PubMed
  22. Mol Psychiatry. 2011 Nov;16(11):1088-95 - PubMed
  23. Brain Res Bull. 2007 Jun 15;73(1-3):143-9 - PubMed
  24. J Neural Transm (Vienna). 2007;114(4):431-44 - PubMed
  25. Circulation. 2011 Feb 22;123(7):731-8 - PubMed
  26. Neuropsychopharmacology. 2004 Apr;29(4):795-8 - PubMed
  27. World J Biol Psychiatry. 2013 Dec;14(8):583-9 - PubMed
  28. Eur J Hum Genet. 2013 Jun;21(6):659-65 - PubMed
  29. J Affect Disord. 2013 Sep 5;150(2):415-23 - PubMed
  30. Neurobiol Aging. 2005 Jan;26(1):115-23 - PubMed
  31. Biol Psychiatry. 2008 Sep 15;64(6):527-32 - PubMed
  32. Acta Psychiatr Scand Suppl. 2004;(420):55-64 - PubMed
  33. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10440-4 - PubMed
  34. Science. 2006 Oct 6;314(5796):140-3 - PubMed
  35. J Neurosci Res. 2007 Feb 15;85(3):525-35 - PubMed
  36. Exp Neurol. 2014 Sep;259:75-80 - PubMed
  37. World J Biol Psychiatry. 2012 Jan;13(1):39-47 - PubMed
  38. Am J Hum Genet. 2011 Jan 7;88(1):76-82 - PubMed
  39. Mol Cell Neurosci. 2004 May;26(1):166-81 - PubMed
  40. Neurobiol Aging. 2007 Sep;28(9):1436-45 - PubMed
  41. Exp Physiol. 2009 Oct;94(10):1062-9 - PubMed
  42. PLoS One. 2013 Apr 18;8(4):e50762 - PubMed
  43. Brain Res Dev Brain Res. 2002 Dec 15;139(2):139-50 - PubMed

Publication Types